Clinical Trials Logo

Sars-Cov-2 Virus Infection clinical trials

View clinical trials related to Sars-Cov-2 Virus Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04956224 Completed - Clinical trials for SARS-CoV-2 Virus Infection

Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

Start date: August 9, 2021
Phase: Phase 3
Study type: Interventional

This is a A Phase III, Open label, Multicenter, Single Arm Study to assess the Safety, Tolerability and Immunogenicity of VLA2001 in volunteers aged ≥ 56 years. Approximately 300 participants are enrolled in a non-randomized manner.

NCT ID: NCT04864561 Completed - Clinical trials for SARS-CoV-2 Virus Infection

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

COV-COMPARE
Start date: April 26, 2021
Phase: Phase 3
Study type: Interventional

This is a multicentre, randomized, observer-blind, active-controlled, superiority, study in adults to compare the immunogenicity of VLA2001 to AZD1222 in terms of GMT of SARS-CoV-2-specific neutralising antibodies. Furthermore, VLA2001 will be compared to placebo in an adolescent population.

NCT ID: NCT04671017 Completed - Clinical trials for SARS-CoV-2 Virus Infection

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

Start date: December 16, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

A multicenter, 3-arm randomized dose finding study in the UK to evaluate safety, tolerability and immunogenicity of a vaccine candidate against Covid-19. 150 healthy volunteers will be enrolled and receive two shots of the vaccine candidate. All participants who receive two doses of the vaccine candidate will be invited to participate in the Booster phase.